Clare Market Investments LLC Eli Lilly & CO Transaction History

Clare Market Investments LLC

$379 Billion
Q1 2025

A detailed history of Clare Market Investments LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Clare Market Investments LLC holds 4,209 shares of LLY stock, worth $3.14 Million. This represents 0.92% of its overall portfolio holdings.

Number of Shares

4,209

Previous 2,206 90.8%

Holding current value

$3.14 Million

Previous $1.7 Billion 104.12%

% of portfolio

0.92%

Previous 0.4%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 10, 2025	BUY	$725.72 - $929.72 $1.45 Million - $1.86 Million	2,003 Added 90.8%	4,209 $3.48 Billion
Q4 2024 Feb 07, 2025	BUY	$727.2 - $932.06 $1.6 Million - $2.06 Million	2,206 New	2,206 $1.7 Billion
Q3 2024 Feb 20, 2025	BUY	$772.14 - $960.02 $733,533 - $912,019	950 Added 48.4%	2,913 $2.58 Billion
Q2 2024 Feb 20, 2025	BUY	$724.87 - $909.04 $218,910 - $274,530	302 Added 18.18%	1,963 $1.78 Billion
Q1 2024 Feb 20, 2025	SELL	$592.2 - $792.28 $38,493 - $51,498	-65 Reduced 3.77%	1,661 $1.29 Billion
Q4 2023 Feb 20, 2025	BUY	$525.19 - $619.13 $14,705 - $17,335	28 Added 1.65%	1,726 $1.01 Billion
Q3 2023 Feb 20, 2025	SELL	$434.7 - $599.3 $120,411 - $166,006	-277 Reduced 14.03%	1,698 $912 Million
Q2 2023 Feb 20, 2025	SELL	$350.74 - $468.98 $81,020 - $108,334	-231 Reduced 10.47%	1,975 $926 Million
Q1 2023 Feb 20, 2025	SELL	$310.63 - $364.82 $119,903 - $140,820	-386 Reduced 15.86%	2,048 $703 Million
Q4 2022 Feb 20, 2025	SELL	$321.55 - $374.67 $381,036 - $443,983	-1,185 Reduced 32.74%	2,434 $891 Million
Q3 2022 Feb 20, 2025	BUY	$296.48 - $337.87 $131,340 - $149,676	443 Added 13.95%	3,619 $1.17 Billion
Q2 2022 Feb 20, 2025	SELL	$278.73 - $327.27 $34,005 - $39,926	-122 Reduced 3.7%	3,176 $1.03 Billion
Q1 2022 Feb 20, 2025	SELL	$234.69 - $291.66 $321,994 - $400,157	-1,372 Reduced 29.38%	3,298 $945 Million
Q4 2021 Feb 20, 2025	SELL	$224.85 - $279.04 $30,129 - $37,391	-134 Reduced 2.79%	4,670 $1.29 Billion
Q3 2021 Feb 20, 2025	BUY	$221.6 - $272.71 $373,396 - $459,516	1,685 Added 54.02%	4,804 $1.11 Million
Q2 2021 Feb 20, 2025	SELL	$180.55 - $233.54 $255,478 - $330,459	-1,415 Reduced 31.21%	3,119 $716 Million
Q1 2021 Feb 20, 2025	SELL	$164.32 - $212.72 $11,995 - $15,528	-73 Reduced 1.58%	4,534 $847 Million
Q4 2020 Feb 20, 2025	BUY	$130.46 - $172.63 $601,029 - $795,306	4,607 New	4,607 $778 Million
Q3 2020 Feb 20, 2025	SELL	$146.22 - $169.13 $204,123 - $236,105	-1,396 Closed	0 $0
Q2 2020 Feb 20, 2025	SELL	$136.42 - $164.18 $110,500 - $132,985	-810 Reduced 36.72%	1,396 $229 Million
Q4 2019 Feb 20, 2025	BUY	$106.92 - $132.43 $307,929 - $381,398	2,880 Added 130.55%	5,086 $668 Million

Others Institutions Holding LLY

# of Institutions

4,383

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $710B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clare Market Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clare Market Investments LLC with notifications on news.

Account

Clare Market Investments LLC Eli Lilly & CO Transaction History